FIELD: medicine.
SUBSTANCE: invention relates to biotechnology and represents antibody or its fragment, which is able to bind with homologue 10 of protein Frizzled (FZD10), such as monoclonal mouse antibody, hybrid antibody, chimeric and humanised antibody. Also claimed are hybridoma clones, producing antibody, as well as method of treatment of prevention of FZD10-associated disease; method of diagnostics or prediction of FZD10-associated disease; method of visualisation in vivo FZD10 in a subject; pharmaceutical composition and set, containing antibody.
EFFECT: treatment with claimed antibodies makes it possible to improve clinical outcome in case of diseases associated with homologue to of protein Frizzled.
44 cl, 45 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHIMERIC THERAPEUTIC ANTI-CD-37 ANTIBODY HH1 | 2012 |
|
RU2658438C2 |
| MONOCLONAL ANTIBODY AGAINST FZD10, ITS USE | 2017 |
|
RU2765431C2 |
| NOVEL ANTI-IL13 ANTIBODIES AND USE THEREOF | 2004 |
|
RU2487887C2 |
| ANTIBODIES RAISED AGAINST α-INTERFERON | 2002 |
|
RU2314317C2 |
| ANTI-C5 ANTIBODIES AND THEIR USE | 2018 |
|
RU2774716C2 |
| ANTI-c-Met ANTIBODY | 2009 |
|
RU2560257C2 |
| ANTIBODIES TO HER3 AND APPLICATION THEREOF | 2010 |
|
RU2560583C2 |
| HUMANISED ANTIBODIES AGAINST TNFα | 2012 |
|
RU2549700C1 |
| NEW COMPLETELY HUMAN VAP-1 MONOCLONAL ANTIBODIES | 2008 |
|
RU2459832C2 |
| AGONIST NOTCH3 ANTIBODIES AND APPLICATION THEREOF FOR TREATING NOTCH3-ASSOCIATED DISEASES | 2007 |
|
RU2461569C2 |
